This article presents a large, population-based study using UK primary care data to identify comorbid conditions associated with lung cancer in never-smokers (LCINS).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
June 5, 2025
This article reviews recent efforts to evaluate the use of osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in the neoadjuvant setting for patients with resectable EGFR-mutant non-small cell lung cancer (NSCLC).
May 7, 2025
This retrospective analysis compared three-port and four-port robotic-assisted thoracoscopic surgery (RATS) lobectomy for non-small cell lung cancer (NSCLC)(n=121, 2020–2021). Demographics, tumor characteristics, complications, and lymph node yields were similar between groups.
April 17, 2025
This article presents a comprehensive epidemiological analysis of lung cancer, focusing on subtype-specific patterns worldwide.
March 6, 2025
Lung cancer remains the leading cause of cancer-related deaths, and low-dose computed tomography screening can reduce mortality for high-risk individuals.
January 2, 2025
This article addresses the evolving role of invasive mediastinal restaging in managing resectable stage II and III NSCLC in the era of neoadjuvant chemoimmunotherapy.
January 2, 2025
This study evaluates the outcomes of bilateral lung transplantation (LTx) using grafts from donors aged 70 years or older, compared with those from younger donors. Conducted at a single center in Leuven, Belgium, the retrospective cohort study included 69 older donors, matched 1:1 with younger donors based on key variables.
November 21, 2024
Current guidelines advocate for surgically placed intercoastal catheters (ICC) for pain optimization following minimally invasive anatomic lung resection. This double-blind, randomized study aimed to determine the efficacy of loco-regional continuous ropivacaine application through ICC as a method of providing analgesia postoperatively.
October 24, 2024
This article evaluates the effectiveness of neoadjuvant immunotherapy combined with chemotherapy (IC+Chemo) in treating non-small cell lung cancer (NSCLC). This large-scale study involved 1,092 patients from 11 medical centers and compared outcomes between those who received IC+Chemo and those who received chemotherapy alone.
May 29, 2024
This study evaluated the surgical and oncological results of RATS thymectomy to demonstrate the approach as technically safe with acceptable outcomes. Of 669 patients, complete thymectomy was performed in 98 percent of cases and in 8.5 percent of those cases, resection of surrounding structures was undertaken.